| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/19/1997 | US5658568 Cytotoxic drug therapy |
| 08/19/1997 | US5658564 Xenograft thymus |
| 08/19/1997 | CA1339339C Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
| 08/19/1997 | CA1339307C Oral immunization by transgenic plants |
| 08/15/1997 | WO1997029768A1 Salmonella typhimurium vaccine |
| 08/15/1997 | CA2244807A1 Salmonella typhimurium vaccine |
| 08/14/1997 | WO1997029195A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 08/14/1997 | WO1997029185A1 Recombinant phages |
| 08/14/1997 | WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a) |
| 08/14/1997 | WO1997029129A1 Antibodies specific for mature complexes formed by hepatitis c virus glycoproteins e1 and e2 |
| 08/14/1997 | WO1997028828A1 Composition comprising interleukin-1 inhibitor and controlled release polymer |
| 08/14/1997 | WO1997028822A1 Composition and method for causing photodynamic damage to target cells |
| 08/14/1997 | WO1997028821A1 Immunological methods for the treatment of gastrointestinal cancer |
| 08/14/1997 | WO1997028820A1 Vaccines against varicella zoster virus gene 63 product |
| 08/14/1997 | WO1997028819A1 Vaccine against hantavirus |
| 08/14/1997 | WO1997028818A1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope |
| 08/14/1997 | WO1997028817A1 Receptor ligand-facilitated delivery of biologically active molecules |
| 08/14/1997 | WO1997028816A1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| 08/14/1997 | WO1997028809A1 Adjuvant properties of poly(amidoamine) dendrimers |
| 08/14/1997 | DE19604380A1 Tumour vaccine for treatment of, e.g. carcinoma, lymphoma or leukaemia |
| 08/14/1997 | CA2733866A1 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 08/14/1997 | CA2539273A1 A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof |
| 08/14/1997 | CA2249544A1 Adjuvant properties of poly(amidoamine) dendrimers |
| 08/14/1997 | CA2245783A1 Fhit proteins and nucleic acids and methods based thereon |
| 08/14/1997 | CA2244792A1 Recombinant phages |
| 08/14/1997 | CA2244110A1 Novel methods of vaccination and vaccines thereof comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope |
| 08/13/1997 | EP0789077A1 Viral material and nucleotide fragments associated with multiple sclerose having diagnostic, prophylactic and therapeutical uses |
| 08/13/1997 | EP0789032A2 Method for preparing a monoclonal antibody that provides an equimolar response to free and complexed analyte in a monoclonal/polyclonal sandwich immunoassay |
| 08/13/1997 | EP0789031A2 Acellular vaccine |
| 08/13/1997 | EP0788800A1 Method and kit for inducing immunological tolerance |
| 08/13/1997 | EP0788514A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 08/13/1997 | EP0788513A1 Binding agents to cd23 |
| 08/13/1997 | EP0788372A1 Attenuated canine parvovirus vaccine |
| 08/13/1997 | EP0788370A1 Cyclic semi-random peptide libraries |
| 08/13/1997 | EP0689430B1 Superparamagnetic particles, process for producing the same and their use |
| 08/13/1997 | EP0671948B1 Vaccine composition containing adjuvants |
| 08/13/1997 | EP0567490B1 Non-depleting cd4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (iddm) |
| 08/13/1997 | EP0489138B1 Vaccine composition for treating human Chlamydia infections |
| 08/13/1997 | EP0458937B1 Variants of pai-2 |
| 08/13/1997 | CN1156966A Polynucleotide vaccine for papillomavirus |
| 08/13/1997 | CN1156625A Preparation of fulminant infectious disease bigeminy vaccine of freshwater fishes and immunifaction |
| 08/13/1997 | CN1035628C Method for producing monoclonal antibodies |
| 08/13/1997 | CA2197265A1 Target cell-specific vectors for inserting genes into cells, pharmaceuticals comprising such vectors and their use |
| 08/12/1997 | US5656732 Polypeptides of feline T-cell lymphotrophic lentivirus |
| 08/12/1997 | US5656730 Stabilized monomeric protein compositions |
| 08/12/1997 | US5656597 Lyospheres comprising gonadotropin |
| 08/12/1997 | US5656595 Culture product; exchange with protin p21-guanosine diphosphate complex |
| 08/12/1997 | US5656488 Recombinant avirulent salmonella antifertility vaccines |
| 08/12/1997 | US5656485 Eimeria antigenic composition which elicits antibodies against avian coccidiosis |
| 08/12/1997 | US5656457 DNA sequence for the unique sequence herpes simplex virus type 2-glycoprotein G protein and method of expressing said unique sequence of HSV-2gG |
| 08/12/1997 | US5656455 Adenylate cyclase stimulating factor |
| 08/12/1997 | US5656451 Therapy, prevention, diagnosis of lyme disease |
| 08/12/1997 | US5656444 Forming monoclonal antibody-oncofetal protein complex |
| 08/12/1997 | US5656436 Analog of Haemophilus Hin47 with reduced protease activity |
| 08/12/1997 | US5656423 Genetic engineering; urogenital cancer detection |
| 08/12/1997 | US5656298 Immunobooster for delayed release of immunogen |
| 08/12/1997 | US5656275 Recombinant raccoon pox virus comprising the DNA encoding the nucleocapsid protein of feline infectious peritonitis virus |
| 08/12/1997 | US5656273 Administering; treats infection caused by helminth, schistosoma, and metazoan |
| 08/12/1997 | US5656271 Oral vaccine comprising anti-idiotypic antibody to chlamydia glycolipid exoantigen and process |
| 08/12/1997 | CA1339268C Human papilloma virus type 57, the dna thereof and the proteins encoded thereby |
| 08/12/1997 | CA1339267C Felv-infected feline cell line |
| 08/12/1997 | CA1339266C Production of streptococcal m protein immunogens and molecular probes |
| 08/12/1997 | CA1339265C Ibdv vp2 epitope recognised by virus neutralising and protective monoclonal antibodies |
| 08/12/1997 | CA1339263C Fusion proteins and particles |
| 08/12/1997 | CA1339260C Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same |
| 08/07/1997 | WO1997028273A1 Expression of group b neisseria meningitidis outer membrane (mb3) protein from yeast and vaccines |
| 08/07/1997 | WO1997028265A1 Measles immunization by dna transcription unit inoculation |
| 08/07/1997 | WO1997028264A1 A novel gene encoding an outer membrane protein of helicobacter pylori and a recombinant microorganism expressing the same |
| 08/07/1997 | WO1997028263A1 Recombinant expression of s-layer proteins |
| 08/07/1997 | WO1997028262A1 Lyst1 and lyst2 gene compositions and methods of use |
| 08/07/1997 | WO1997028259A1 Gene expression vectors which generate an antigen specific immune response and methods of using the same |
| 08/07/1997 | WO1997028255A1 Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer |
| 08/07/1997 | WO1997028254A1 Antigenic modulation of cells |
| 08/07/1997 | WO1997028251A1 Combined radiotherapy and immunotherapy to treat cancer |
| 08/07/1997 | WO1997028191A1 Mhc complexes and uses thereof |
| 08/07/1997 | WO1997028190A1 Cytokine antagonists and agonists |
| 08/07/1997 | WO1997028186A1 PURIFIED SR-p70 PROTEIN |
| 08/07/1997 | WO1997027876A1 Immunotherapy sensitization of cancer therapy |
| 08/07/1997 | WO1997027872A1 Immunomodulatory methods using oligosaccharides |
| 08/07/1997 | WO1997027742A1 Method of protein production using mitochondrial translation system |
| 08/07/1997 | DE19603649A1 Rekombinante Expression von S-Layer-Proteinen Recombinant expression of S-layer proteins |
| 08/07/1997 | CA2279978A1 Antigenic modulation of cells |
| 08/07/1997 | CA2244989A1 Expression of group b neisseria meningitidis outer membrane (mb3) protein from yeast and vaccines |
| 08/07/1997 | CA2244841A1 Combined radiotherapy and immunotherapy to treat cancer |
| 08/07/1997 | CA2244755A1 Mhc complexes and uses thereof |
| 08/07/1997 | CA2244727A1 Immunomodulatory methods using oligosaccharides |
| 08/07/1997 | CA2244709A1 Method of protein production using mitochondrial translation system |
| 08/06/1997 | EP0787799A1 Staphylococcus aureus WCUH29 SpoIIIE Protein |
| 08/06/1997 | EP0787797A1 Human 5-HT1D receptor (serotonin receptor), process for preparing the same, its uses, antibodies directed against this receptor and transgenics expressing it |
| 08/06/1997 | EP0787796A1 Protective epitopes from adenylate cyclase-hemolysin(AC-Hly) and their use for treatment or prevention of Bordetella infections |
| 08/06/1997 | EP0787211A1 Method for identifying protective antigens for eliciting neutralizing antibodies |
| 08/06/1997 | EP0787191A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 08/06/1997 | EP0787190A2 Hepatitis e virus antigens and uses therefor |
| 08/06/1997 | EP0787184A1 Recombinant alternaria alternata allergens |
| 08/06/1997 | EP0787151A1 Monoclonal antibody fragments having immunosuppressant activity |
| 08/06/1997 | EP0787150A1 SYNTHETIC IgE MEMBRANE ANCHOR PEPTIDE IMMUNOGENS FOR THE TREATMENT OF ALLERGY |
| 08/06/1997 | EP0787147A1 Compositions and treatment for multiple sclerosis |
| 08/06/1997 | EP0787144A1 Major outer membrane protein cd of moraxella |
| 08/06/1997 | EP0787139A1 Synthetic peptides and vaccines comprising same |
| 08/06/1997 | EP0787138A1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |